Potential Bidders Are Looking at Shell’s Chemical Assets. How Investors Should View a Potential Sale.

Chemicals Sale Signals Portfolio Discipline

Potential buyers are looking at Shell’s U.S. chemicals business, and investors should see that as part of the company’s effort to sell assets that no longer fit its main priorities. Reports say Exxon Mobil Corporation, LyondellBasell Industries N.V., Apollo Global Management, Inc. (APO), and Kuwait Petroleum Corporation’s chemicals unit made non-binding offers in July for all or part of the business. 

The portfolio includes four sites in Louisiana, Texas, and Pennsylvania that make chemicals used in plastics, detergents, and pharmaceuticals. Its Monaca site alone can produce 1.6 million tonnes of polymers a year. The assets could sell for up to $8 billion, though that is far below what Shell plc has invested over time.

This fits Shell’s broader strategy of pruning non-core holdings to fund higher-return growth. Its pending $16.4 billion purchase of ARC Resources Ltd. would add about 370,000 barrels of oil equivalent per day from Canada’s Montney basin and support 4% yearly production growth through 2030. ARC Resources shareholders approved the deal, which is expected to close in H2 2026 after Investment Canada Act clearance. Shell plc expects it to add to free cash flow per share from 2027. 

The company is also growing its LNG business through a deal with Metlen Energy & Metals S.A. (MTLN.L.EB), moving ahead with deepwater projects in Nigeria, and returning cash to shareholders. It has completed a $3.5 billion buyback, started another $3 billion program, and sold Jiffy Lube for $1.3 billion.

Analysts Weigh the Strategic Trade-Off

Shell is set to report Q3 results on Oct. 29. Analysts expect earnings of $2.72 per share for the September quarter, up 46.24% from $1.86 a year ago. For all of 2026, Wall Street expects Shell to earn $10.36 per share, a 64.44% increase from $6.30 in 2025.

Analyst views are mostly positive, though not everyone is equally bullish. Scotiabank’s Betty Zhang kept her “Sector Outperform” rating and raised her price target to $122 from $91. Jefferies analyst Mark Wilson also maintained a “Buy” rating and increased his target to $122.40 from $119.70. Wells Fargo’s Sam Margolin was more cautious after Shell’s Q2 report. On July 31, he maintained an “Equal-Weight” rating, though he still raised his target to $105 from $100.

Overall, all 25 analysts surveyed rate SHEL stock a consensus “Moderate Buy,” with an average price target of $99.23. That points to about 9% upside from current levels.

Conclusion

A chemicals sale looks like a sensible move for Shell if management can secure a price that reflects the assets’ strategic value and direct the proceeds toward higher-return gas, LNG, and upstream opportunities; debt reduction; or shareholder returns. Reported bidder interest gives Shell negotiating leverage, but investors should remain focused on the final valuation, especially since an $8 billion deal would reportedly be well below Shell’s cumulative investment in the facilities. Given Shell’s strong cash flow, lower debt, and growth from ARC, shares appear more likely to trend higher over time, although oil prices and deal execution could keep the path uneven.

On the date of publication, Ebube Jones did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Barchart.com